acebutolol has been researched along with heparitin sulfate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jacotot, B; Moczar, M; Robert, AM; Robert, L | 1 |
Glushka, JN; Perlin, AS | 1 |
Brandley, BK; Casabonne, M; Castellot, JJ; Foxall, C; Fugedi, P; Peto, C; Schaefer, ME; Wei, Z | 1 |
3 other study(ies) available for acebutolol and heparitin sulfate
Article | Year |
---|---|
Effect of an alpha-blocker (Nicergoline) and of a beta-blocker (Acebutolol) on the in vitro biosynthesis of vascular extracellular matrix.
Topics: Acebutolol; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta; Arteries; Carbon Radioisotopes; Collagen; Culture Techniques; Extracellular Matrix Proteins; Glucosamine; Glycosaminoglycans; Heparitin Sulfate; Hyaluronic Acid; Hydroxyproline; Lysine; Muscle, Smooth, Vascular; Nicergoline; Proline; Rabbits; Tritium | 2001 |
Formation of disaccharides related to heparin and heparan sulfate by chemical modification of maltose.
Topics: Carbohydrate Conformation; Carbohydrate Sequence; Disaccharides; Heparin; Heparitin Sulfate; Magnetic Resonance Spectroscopy; Maltose; Molecular Sequence Data | 1990 |
Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
Topics: Animals; Binding, Competitive; Cell Division; Cells, Cultured; Endothelium, Vascular; Fibroblast Growth Factor 2; Heparitin Sulfate; Humans; Maltose; Neovascularization, Physiologic; Oligosaccharides; Protein Binding; Rats; Recombinant Proteins; Structure-Activity Relationship; Sulfates | 1996 |